Adverum Biotechnologies, Inc. (ADVM) NASDAQ

2.95

+0.09(+3.15%)

Updated at August 18 02:42PM

Currency In USD

Valuation

Market Cap92.38M
Enterprise Value123.43M
P/E Ratio-0.34
PEG Ratio0.01
Price/Sales Ratio61.9
Price/Book Ratio-3.07
Enterprise/Revenue111.71
Enterprise/EBITDA-0.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-183.87
Operating Margin-65.49

Management Effectiveness

Return On Assets-1.91
Return On Equity-3.33

Income Statement

Revenue1M
Revenue/Share0.05
Gross Profit-2.65M
EBITDA-127.27M
Net Income-130.93M
Diluted EPS-6.62

Balance Sheet

Total Cash44.4M
Total Cash/Share2.11
Total Debt92.22M
Total Debt/Equity-4.56
Current Ratio1.54
Book Value Per Share-0.96

Price History

52-Week Change-59.31
52-Week High8.56
52-Week Low1.78
Moving Average 50 Days2.52
Moving Average 200 Days4.06

Statistics

Average Volume207,058
Shares Outstanding20.98M
% Held by Institutions73.02

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 21, 2024